If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19 - 15/02/21
Graphical abstract |
Key words : ACE2, atopic dermatitis, COVID-19, IL-17 antibody, psoriasis, SARS-COV-2
Funding sources: None. |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: Not applicable. |
|
Reprints not available from the authors. |
Vol 84 - N° 3
P. e173 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.